| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 5,334,100 | 5,884,500 | 6,747,900 | 5,145,900 | | Cost of Revenue | 3,898,700 | 4,057,600 | 4,756,400 | 3,542,500 | | | Gross Profit | 1,435,400 | 1,826,900 | 1,991,500 | 1,603,400 | | | Operating Expenses | | Research Development | 258,600 | 243,300 | 255,700 | 219,400 | | Selling General and Administrative | 982,700 | 825,100 | 854,400 | 835,800 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 194,100 | 758,500 | 881,400 | 548,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 194,100 | 758,500 | 881,400 | 548,200 | | Interest Expense | 249,200 | 249,300 | 269,400 | 274,500 | | Income Before Tax | (55,100) | 509,200 | 612,000 | 273,700 | | Income Tax Expense | 161,400 | 87,900 | 137,200 | 73,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (222,800) | 420,100 | 472,300 | 203,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (222,800) | 420,100 | 472,300 | 203,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($222,800) | $420,100 | $472,300 | $203,900 |
|
0.13% Nasdaq 
Income Statement
